Importantly, KDM5B is an H3K4 demethylase that is induced in differentiated leukemia cells, and the overexpression of KDM5B abrogates the oncogenic potential of LSC in MLL-rearranged AML [130]. Here, KMT2A is linked to acute myeloid leukemia.